Novella Clinical Inc - NC New Hanover, Wilmington 28405

Novella Clinical Inc entered the industry of Medical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417115, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Nick Dyer, Executive Vice President by calling (910) 799-3463 during business hours. You can also write to the business’ Branch at 575 Military Cutoff Road, Wilmington, North Carolina NC 28405. You can also visit the company’s website at sallingtate.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Novella Clinical Inc
Representative: Nick Dyer, Executive Vice President
Place of Business: 575 Military Cutoff Road, Wilmington, NC 28405
Contact Number: (910) 799-3463
Website: sallingtate.com
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 5417115
Locality: Branch
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Novella Clinical Inc is a company operating from New Hanover, North Carolina providing professional Medical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417115 as Medical Research.

With a current employee count of 1 to 4, Novella Clinical Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Nick Dyer, Executive Vice President at (910) 799-3463 for related queries, or to locate its Branch using the coordinates 34.25206,-77.82649.

The Branch can also be found at the street address 575 Military Cutoff Road in Wilmington, North Carolina 28405 and can be engaged online through the company website at sallingtate.com, the company Twitter , and Facebook page .